"臨床的および行動的特徴を用いたアルツハイマー病の予測のための説明可能な機械学習モデルの開発"への訂正 [MethodsX 15 (2025) 103491]
Rajkumar Govindarajan1, K Thirunadanasikamani1, Komal Kumar Napa2
1Department of Computer Science and Engineering, St. Peter's Institute of Higher Education and Research, Avadi, Chennai, India.
MethodsX
|August 21, 2025
まとめ
この研究は,以前に発表された論文 DOI を訂正しています. 訂正は,この分野における将来の研究のための正確な引用と参照を保証します.
科学分野:
- 科学出版
- 研究の整合性
背景:
- 科学文献の正確性を確保することは極めて重要です.
- 適切な引用は研究の再現性を促進する.
研究 の 目的:
- 記事のDOIのエラーを修正する.
- 科学的な記録の 整合性を維持するために
主な方法:
- 訂正通知が出された.
- 正確なDOIが提供されました.
主要な成果:
- 記事のDOIが更新されました.
- 科学的な記録は 今では正確です
結論:
- この訂正は研究基準に準拠しています
- 正確なDOIは科学的なコミュニケーションに不可欠です.
さらに関連する動画
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
9.4K
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
663
関連する概念動画
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666